Goldman Sachs’s NxStage Medical Inc. NXTM Stock Holding History

Goldman Sachs’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-25,000	Closed	-$375K	–	7399
2016 Q1	$375K	Buy	+25,000	New	+$419K	﹤0.01%	5047
2015 Q4	–	Sell	-50,000	Closed	-$789K	–	7497
2015 Q3	$789K	Hold	50,000	–	–	﹤0.01%	4700
2015 Q2	$714K	Buy	+50,000	New	+$847K	﹤0.01%	4858
2013 Q4	–	Sell	-96,200	Closed	-$1.27M	–	6879
2013 Q3	$1.27M	Sell	96,200 -3,800	-4%	-$49.8K	﹤0.01%	4382
2013 Q2	$1.43M	Buy	+100,000	New	+$1.26M	﹤0.01%	4060

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Goldman Sachs's NXTM Position: Q1 2019 in Review

Goldman Sachs sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 846,876 shares — an estimated $24.2M sold.

Goldman Sachs first reported a position in NXTM in Q2 2013 and held it in 22 quarters. The position peaked at $35.1M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Goldman Sachs reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Goldman Sachs sold 846,876 NxStage Medical Inc. shares in Q1 2019, an estimated $24.2M.
Goldman Sachs first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 22 quarters.
Goldman Sachs's NxStage Medical Inc. position peaked at $35.1M in Q3 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.